(R)-69

维基百科,自由的百科全书
跳转到导航 跳转到搜索
(R)-69
File:(R)-69.svg
临床资料
其他名称R-69; 3IQ
药物类别Non-hallucinogenic Serotonin 5-HT2A receptor agonist
识别信息
  • 3-[(5R)-5-methyl-1,2,5,6-tetrahydropyridin-3-yl]-1H-pyrrolo[2,3-b]pyridine
CAS号2765652-48-8  checkY
PubChem CID
ChemSpider
UNII
ChEMBL
PDB配体ID
E编码{{#property:P628}}
CompTox Dashboard (EPA)
  • {{#property:P3117}}Module:EditAtWikidata第29行Lua错误:attempt to index field 'wikibase' (a nil value)
ECHA InfoCard{{#property:P2566}}Module:EditAtWikidata第29行Lua错误:attempt to index field 'wikibase' (a nil value)
化学信息
化学式C13H15N3
摩尔质量213.28 g·mol−1
3D模型(JSmol
  • C[C@@H]1C=C(CNC1)c1c[NH]c2ncccc12
  • InChI=1S/C13H15N3/c1-9-5-10(7-14-6-9)12-8-16-13-11(12)3-2-4-15-13/h2-5,8-9,14H,6-7H2,1H3,(H,15,16)/t9-/m1/s1
  • Key:HNDPIXZRQWKEFZ-SECBINFHSA-N

(R)-69也称为3IQ是一种含氮有机化合物,分子式C
13
H
15
N
3
,属于色胺的类似物,由布莱恩·L·罗斯英语Bryan Roth及其同事在2022年为5-HT2A受体激动剂研发,可作为迷幻药物[1][2]

参考文献[编辑]

  1. ^ Duan W, Cao D, Wang S, Cheng J. Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants. Chemical Reviews. January 2024, 124 (1): 124–163. PMID 38033123. doi:10.1021/acs.chemrev.3c00375. Very recently, the docking of a bespoke tetrahydropyridines (THPs) library combined with a structure-based optimization approach by Kaplan et al. led to the discovery of novel 5-HT2AR agonists with antidepressant activity in mouse models.202 The docking of a virtual library of 75 million THP compounds against the model of 5-HT2AR yielded 17 initial hits, among which 4 compounds showed low-micromolar activities at either 5-HT2AR or 5-HT2BR. Further modifications afforded [...] compounds (R)-69 (170) and (R)-70 (171) as agonists (Ki = 680 and 880 nM; EC50 = 41 nM (90.1%) and 110 nM (73.3%) in the calcium flux assay, respectively) (Figure 14D). Both compounds showed moderate binding selectivity against the 5-HT2BR and 5-HT2CR, and overall better selectivity profiles than those of classic psychedelic 5-HT2AR agonists. Interestingly, compounds (R)-69 and (R)-70 were pharmacologically profiled as G protein-biased 5-HT2AR agonists and were demonstrated as nonhallucinogenic in the HTR test and could block LSD-induced HTR effects. Very importantly, the compounds exhibited both acute and lasting (at least over 24 h) antidepressant effects in several mouse behavioral models.202 
  2. ^ Kaplan AL, Confair DN, Kim K, Barros-Álvarez X, Rodriguiz RM, Yang Y, Kweon OS, Che T, McCorvy JD, Kamber DN, Phelan JP, Martins LC, Pogorelov VM, DiBerto JF, Slocum ST, Huang XP, Kumar JM, Robertson MJ, Panova O, Seven AB, Wetsel AQ, Wetsel WC, Irwin JJ, Skiniotis G, Shoichet BK, Roth BL, Ellman JA. Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity. Nature. October 2022, 610 (7932): 582–591. Bibcode:2022Natur.610..582K. PMC 9996387可免费查阅. PMID 36171289. S2CID 252598838. doi:10.1038/s41586-022-05258-z. 

外部链接[编辑]